Kermish oversees Protolabs’ global technology organization, leading its strategic initiatives and artificial intelligence (AI) strategy. Kermisch brings more than 25 years of senior executive experience at technology and R&D organizations across diverse industries, including manufacturing, software, and retail. Most recently, he served as Chief Technology Officer for Emergent Software, a technology company specializing in software development, cloud transformation, AI, and data engineering solutions. Prior to Emergent, he was Global Chief Digital and Information Officer at Case New Holland (NYSE: CNH), a manufacturer of agriculture and construction equipment where he focused on developing autonomous vehicles, precision farming applications, and electric powertrains.
As AI adoption accelerates across medtech, manufacturers face a critical question: how do you harness AI’s speed and scale without compromising quality, compliance, or engineering accountability?
In this session, Protolabs experts examine how a human‑in‑the‑loop approach to AI is redefining digital manufacturing for medical devices. From AI‑enhanced DFM and automated inspection to intelligent similarity analysis and documentation support, attendees will learn how AI can reduce design risk, improve manufacturability, and enable faster, more predictable outcomes—without replacing engineering judgment. The discussion will also explore how manufacturers can prepare for the next phase of AI adoption while meeting the demands of ISO 13485, traceability, and regulatory readiness.